| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 161.72B | 164.00B | 136.73B | 134.91B | 130.87B | 136.97B |
| Gross Profit | 92.84B | 91.31B | 59.23B | 62.12B | 63.64B | 70.87B |
| EBITDA | 43.49B | 37.59B | 7.20B | 9.89B | 14.32B | 23.57B |
| Net Income | 25.26B | 24.19B | -28.68B | 8.86B | 30.53B | 25.63B |
Balance Sheet | ||||||
| Total Assets | 374.99B | 394.19B | 335.71B | 348.94B | 340.57B | 327.12B |
| Cash, Cash Equivalents and Short-Term Investments | 97.53B | 92.80B | 71.40B | 97.73B | 78.30B | 97.30B |
| Total Debt | 48.06B | 48.41B | 44.51B | 45.16B | 28.27B | 27.14B |
| Total Liabilities | 115.30B | 141.31B | 115.68B | 114.95B | 95.66B | 98.46B |
| Stockholders Equity | 251.44B | 241.73B | 209.20B | 221.63B | 240.63B | 223.71B |
Cash Flow | ||||||
| Free Cash Flow | 43.42B | 34.75B | -14.38B | 10.18B | 17.88B | 26.53B |
| Operating Cash Flow | 50.85B | 39.00B | -10.84B | 10.81B | 18.38B | 29.97B |
| Investing Cash Flow | -17.17B | -12.26B | -12.30B | 12.95B | -19.59B | -7.22B |
| Financing Cash Flow | -9.78B | -5.46B | -4.43B | -5.43B | -18.88B | 5.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥287.15B | -11.40 | 17.98% | 2.52% | 8.31% | 37.90% | |
69 Neutral | ¥170.81B | 7.96 | 10.05% | 4.61% | 5.86% | 43.24% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥135.78B | 97.57 | 3.38% | 2.38% | -10.00% | -87.03% | |
60 Neutral | ¥39.78B | 9.53 | ― | 4.06% | 2.95% | 174.57% | |
54 Neutral | ¥66.45B | 111.53 | 1.59% | 2.09% | -9.60% | -69.84% | |
43 Neutral | ¥19.41B | -95.92 | ― | ― | -17.46% | -28.71% |